A&T Income Statement | StatInvestor

Health Care & Life Sciences » Medical Equipment & Supplies | A&T Corp.

A&T Corp. | Income Statement

Fiscal year is January-December. All values JPY Millions.

2013

2014

2015

2016

2017

Sales/Revenue

9,221

9,570

10,138

10,234

10,372

Cost of Goods Sold (COGS) incl. D&A

5,081

5,320

5,436

5,665

5,943

Gross Income

4,140

4,250

4,702

4,570

4,429

SG&A Expense

3,398

3,394

3,499

3,554

3,656

EBIT

743

856

1,202

1,015

773

Unusual Expense

Non Operating Income/Expense

115

Interest Expense

Pretax Income

719

737

1,178

887

740

Income Tax

247

281

338

235

Consolidated Net Income

471

455

840

652

678

Net Income

471

455

840

652

678

Net Income After Extraordinaries

471

455

840

652

678

Net Income Available to Common

471

455

840

652

678

EPS (Basic)

75.29

72.80

134.18

104.14

108.41

Basic Shares Outstanding

EPS (Diluted)

75.29

72.80

134.18

104.14

108.41

Diluted Shares Outstanding

EBITDA

968

1,076

1,403

1,232

1,036

Non-Operating Interest Income

About A&T

View Profile

Address	Yokohama Plaza Building, 10/F Yokohama Kanagawa 221 Japan
Employees	-
Website	http://www.aandt.co.jp
Updated	09/14/2018
A&T Corp. engages in the development, manufacture, and sale of chemicals, analyzers, computers, and laboratory logistics. Its products include laboratory automation and information system, managed pre-analysis module, electrolyte analyzer, blood coagulation analyzer, glucose analyzer, data verification system, and diagnostic reagents. The company was founded on May 25, 1978 and is headquartered in Yokohama, Japan.